Valuation: Ipca Laboratories Limited

Market Cap 51TCr 528.76Cr 462.08Cr 434.3Cr 396.32Cr 743.82Cr 743.97Cr 5.21TCr 2.01TCr 26TCr 1.99TCr 1.94TCr 83TCr P/E 2027 *
33.3x
P/E 2028 * 28.5x
Enterprise Value 49TCr 517.62Cr 452.35Cr 425.15Cr 387.97Cr 728.15Cr 728.29Cr 5.1TCr 1.97TCr 25TCr 1.94TCr 1.9TCr 81TCr EV / Sales 2027 *
4.5x
EV / Sales 2028 * 3.96x
Free-Float
54.94%
Yield 2027 *
0.29%
Yield 2028 * 0.31%
1 day-0.79%
1 week+1.15%
Current month+0.87%
1 month+4.28%
3 months+25.76%
6 months+28.78%
Current year+39.90%
1 week 1,906.85
Extreme 1906.85
2,039.3
1 month 1,896.85
Extreme 1896.85
2,039.3
Current year 1,392
Extreme 1392
2,039.3
1 year 1,252.95
Extreme 1252.95
2,039.3
3 years 886
Extreme 886
2,039.3
5 years 670
Extreme 670
2,039.3
10 years 200
Extreme 200
2,039.3
Manager TitleAgeSince
Chief Executive Officer 53 01/04/2023
Chief Executive Officer 70 01/04/2023
Chief Tech/Sci/R&D Officer 52 16/10/2023
Director TitleAgeSince
Chairman 79 05/07/2012
Director/Board Member 53 11/11/2008
Director/Board Member 70 01/08/1994
Change 5-day change 1-year change 3-year change Capi.($)
-0.79%+1.15% - - 531.81Cr
+0.45%+2.80%+55.61%+112.70% 1,03800Cr
-0.10%+1.08%+52.78%+66.52% 65TCr
+0.28%+1.31%+19.21%+72.85% 47TCr
-0.19%+0.75%+37.34%+45.03% 36TCr
+0.28%+2.23%+19.12%+25.62% 27TCr
+0.89%+4.26%+12.10%+16.41% 26TCr
+4.34%+7.53%+43.74%+52.27% 21TCr
-0.46%-7.70%-33.40%-59.71% 18TCr
+1.40%+4.28%+33.82%+102.83% 19TCr
Average +0.66%+1.04%+26.70%+48.28% 40.17TCr
Weighted average by Cap. +0.66%+1.47%+36.59%+66.72%

Financials

2027 *2028 *
Net sales 11TCr 115.02Cr 100.51Cr 94Cr 86Cr 161.8Cr 161.83Cr 1.13TCr 437.51Cr 5.62TCr 431.94Cr 422.47Cr 18TCr 12TCr 128.31Cr 112.13Cr 105.39Cr 96Cr 180.5Cr 180.53Cr 1.26TCr 488.06Cr 6.26TCr 481.85Cr 471.29Cr 20TCr
Net income 1.51TCr 16Cr 14Cr 13Cr 12Cr 22Cr 22Cr 156.17Cr 60Cr 773.43Cr 59Cr 58Cr 2.49TCr 1.78TCr 19Cr 16Cr 15Cr 14Cr 26Cr 26Cr 183.52Cr 71Cr 908.85Cr 70Cr 68Cr 2.93TCr
Net Debt -1.06TCr -11Cr -9.74Cr -9.15Cr -8.35Cr -16Cr -16Cr -109.82Cr -42Cr -543.87Cr -42Cr -41Cr -1.75TCr -2TCr -21Cr -18Cr -17Cr -16Cr -29Cr -29Cr -205.78Cr -79Cr -1.02TCr -78Cr -77Cr -3.29TCr
Logo Ipca Laboratories Limited
Ipca Laboratories Limited is an India-based integrated pharmaceutical company. The Company is engaged in manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The Company’s products are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing APIs and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc. and Ipca Pharma Nigeria Ltd.
Employees
17,210
Date Price Change Volume
22/26/22 1,992.20 -0.79% 5,828
21/26/21 ₹2,008.05 -0.15% 10,576
18/26/18 ₹2,011.00 +2.09% 50,010
17/26/17 ₹1,969.80 +1.02% 21,176
16/26/16 ₹1,949.85 +0.80% 16,885
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
1,992.40INR
Average target price
1,972.28INR
Spread / Average Target
-1.01%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!